Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Non Operating Income: 2015-2024

Historic Non Operating Income for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to -$30.3 million.

  • Anaptysbio's Non Operating Income fell 94.09% to -$19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$55.9 million, marking a year-over-year decrease of 206.37%. This contributed to the annual value of -$30.3 million for FY2024, which is 3942.51% down from last year.
  • Per Anaptysbio's latest filing, its Non Operating Income stood at -$30.3 million for FY2024, which was down 3,942.51% from $788,000 recorded in FY2023.
  • In the past 5 years, Anaptysbio's Non Operating Income registered a high of $3.9 million during FY2020, and its lowest value of -$30.3 million during FY2024.
  • For the 3-year period, Anaptysbio's Non Operating Income averaged around -$14.3 million, with its median value being -$13.5 million (2022).
  • In the last 5 years, Anaptysbio's Non Operating Income skyrocketed by 105.82% in 2023 and then plummeted by 3,942.51% in 2024.
  • Over the past 5 years, Anaptysbio's Non Operating Income (Yearly) stood at $3.9 million in 2020, then tumbled by 124.87% to -$982,000 in 2021, then crashed by 1,279.43% to -$13.5 million in 2022, then skyrocketed by 105.82% to $788,000 in 2023, then crashed by 3,942.51% to -$30.3 million in 2024.